STAT Plus: Bristol-Myers Squibb turns to an AI startup to accelerate cancer research
MEL EVANS/AP
The deal is part of a broader effort to shake up the unwieldy and expensive drug development process by using machine learning to analyze data.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario